Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2018-08-16 |
Krystal Biotech (USA - PA) |
$10 million |
private placement |
Frazier Healthcare Partners (USA - WA) |
Rare diseases - Genetic diseases |
Private placement |
2018-08-13 |
Orchard Therapeutics (UK) |
$150 Million |
series C financing round |
ArrowMark Partners (USA - CO) Cormorant Asset Management (USA - MA) Foresite Capital (USA - NY) RA Capital Management (USA - MA) Perceptive Advisors (USA - NY) RTW Investments (USA - NY) Venrock (USA - CA) Foresite Capital (USA - NY) Sphera Global Healthcare (Spain) Medison Ventures Driehaus Capital Management (USA - IL) Ghost Tree Capital Group (USA - NY) Temasek (Singpore) Baillie Gifford (UK) Cowen Healthcare (USA - NY) Agent Capital (USA - MA) |
Rare diseases - Genetic diseases |
Series C financing round |
2018-08-08 |
Beigene (China) |
$903 million |
IPO |
|
Cancer - Oncology |
IPO |
2018-08-06 |
Pharmaxis (Australia) |
A$24 million (£13.4 million - €15.35 million) |
financing round |
Arix Bioscience (UK) BVF Partners (USA - CA) other existing shareholders |
Fibrotic diseases - Inflammatory diseases |
Financing round |
2018-08-03 |
Drug Discovery Gateway Investment Limited Partnership - DDG Fund (Japan) |
|
financing round |
Takeda Pharmaceutical (Japan) Whiz Partners (Japan) |
|
Financing round |
2018-07-31 |
AC Immune (Switzerland) |
$117.5 million |
private placement |
|
Neurological diseases - CNS diseases |
Private placement |
2018-07-28 |
Bluebird Bio (USA - MA) |
$550 million |
private placement |
|
Rare diseases - Genetic diseases |
Private placement |
2018-07-23 |
Azafaros (The Netherlands) |
|
seed financing round |
BioGeneration Ventures (The Netherlands) |
Rare diseases - Genetic diseases - Metabolic diseases |
Financing round |
2018-07-23 |
OliX Pharmaceuticals (South Korea) |
KRW43 billion ($38 million) |
IPO |
|
Fibrotic diseases - Ophtalmological diseases |
IPO |
2018-07-06 |
Oncologie (USA - MA - China) |
$16.5 million |
seed financing round |
Nan Fung Life Sciences (China) Pivotal bioVenture Partners China Fund (China) China Merchant Bank Investments (China) Volcanics Ventures (China) |
Cancer - Oncology |
Financing round |
2018-06-28 |
Innovation Pharmaceuticals (USA - MA) |
$7 million |
private placement |
Aspire Capital (USA - IL) |
Cancer - Oncology - Infectious diseases |
Private placement |
2018-06-25 |
Avrobio (USA - MA) |
$114.7 million |
IPO |
|
Cancer - Oncology - Rare diseases - Genetic diseases - Lysosomal diseases |
IPO |
2018-06-25 |
Akero Therapeutics (USA - MA) |
$65 Million |
series A financing round |
Apple Tree Partners (USA - NY) Atlas Venture (USA - MA) venBio Partners (USA - CA) Versant Ventures (USA - CA) |
Liver diseases - Hepatic diseases |
Series A financing round |
2018-06-12 |
MeiraGTx (USA - NY) |
$75 million |
private placement |
|
Rare diseases - Genetic diseases |
Private placement |
2018-05-30 |
Iontas (UK) |
£556 000 ($737 000) |
grant |
Innovate UK (UK) |
CNS diseases |
Grant |
2018-05-29 |
Melinta Therapeutics (USA - CT) |
|
private placement |
|
Infectious diseases |
Private placement |
2018-05-29 |
Mereo BioPharma (UK) |
|
private placement |
|
Rare diseases |
Private placement |
2018-05-23 |
Celyad (Belgium) |
$54.4 million (approximately €46.1 million), |
private placement |
|
Cancer - Oncology |
Private placement |
2018-05-16 |
HiFiBiO Therapeutics (USA - MA) |
$37.5 million |
series B financing round |
Sequoia China (China) LYFE Capital (China) VI Ventures (China) Nest.Bio Ventures (USA - MA) Legend Star Capital (China) Proxima Ventures (Israel) |
Technology - Services |
Series B financing round |
2018-05-09 |
IGEM Therapeutics (UK) |
£1.45 million |
grant |
Innovate UK (UK) |
Cancer - Oncology |
Grant |